What You Should Know:
– CentralReach, the leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today announced the acquisition of Behavior Science Technology Inc. (BST), a research-backed treatment fidelity platform designed to collect, measure, and track treatment fidelity for Applied Behavior Analysis (ABA) therapy in a standardized way.
– This strategic acquisition marks a significant milestone in CentralReach’s mission to provide the most complete AI-powered care management platform that arms each member of the care team with the tools they need to improve treatment fidelity, RBT retention, supervision effectiveness, and caregiver engagement, while enhancing the quality and consistency of care provided to individuals with autism. Once integrated, Care360 alongside CentralReach’s EMR will offer ABA providers a path towards measurement-based care that can be brought to payers to support their approach towards care.
CentralReach’s Acquisition of BST: Enhancing Applied Behavior Analysis and Autism Care with Innovation and Standardization
CentralReach is the leading provider of software and services for autism and intellectual and developmental disabilities (IDD) care. As the only comprehensive, end-to-end platform, CentralReach enables children and adults diagnosed with autism spectrum disorder (ASD) and related IDDs, along with their caregivers, to unlock potential, achieve better outcomes, and lead more independent lives. Rooted in Applied Behavior Analysis (ABA), CentralReach revolutionizes the delivery of autism and IDD care across home, school, and workplace settings with powerful, intuitive solutions designed for each environment.
In 2024, CentralReach acquired BST, a pioneering tech-enabled, research-based platform that addresses critical gaps in ABA care delivery. The co-founders of BST, Tricia Glick, BCBA, Troy Glick, and Abigail Blackman, PhD, BCBA-D, will join CentralReach to lead the ongoing evolution of BSTperform and its integration into CentralReach’s Care360 platform.
Addressing a Critical Need in ABA Supervision and Care Delivery
The current ABA clinical process involves multiple phases, including:
– Skill gap assessment
– Creation of individualized care plans
– Care delivery
– Data collection and analytics
– Care plan adjustments
A major gap in this process has been the lack of standardized supervision methods during care delivery, making it difficult to ensure that Registered Behavior Technicians (RBTs) consistently follow prescribed care plans. This impacts the quality and fidelity of treatment. BST addresses this gap by introducing the industry’s first tech-enabled platform designed to measure and track treatment fidelity, providing a standardized, transparent approach to improving care delivery.
Key Benefits of BST’s Integration into Care360
The integration of BST into CentralReach’s Care360 platform brings several significant advantages:
– Standardization of Care: The combination of BST’s innovative technology with the Care360 platform standardizes care delivery, creating a consistent framework for evaluating and improving ABA services. This leads to better, more reliable outcomes for individuals receiving ABA care.
– Enhanced RBT Retention: BST’s standardized approach to measuring treatment fidelity supports RBTs in delivering high-quality care. Research shows that this approach increases job satisfaction and clinical competency, resulting in a 500% increase in RBT retention. This aligns with CentralReach’s commitment to fostering professional development and retention of RBTs, which is essential for successful care delivery.
– Pioneering Measurement-Based Care: The acquisition facilitates the adoption of measurement-based, or value-based, care models within the autism and IDD industry. The integration of BSTperform with CentralReach’s clinical solutions provides a standardized method for collecting and aggregating critical data. This data offers quantitative evidence of improved outcomes, a vital component of value-based care.
Expanding CentralReach’s Capabilities
This acquisition marks CentralReach’s second in 2024 and its 14th overall, reflecting the company’s ongoing efforts to expand its capabilities and lead the future of autism and IDD care through innovative and standardized solutions.
“Partnering with CentralReach, the undisputed leader in Autism and IDD care software, was a natural choice for us at BST,” shared Tricia Glick. “CentralReach recognized the potential of our vision and supported us through their investment. We’ve been committed to advancing the field of ABA through our innovative, research-based solutions, and we believe that integrating BSTperform into CentralReach’s comprehensive platform will help further expand our impact. Together, we can accelerate the adoption of standardized treatment fidelity measures and drive meaningful improvements in care delivery and outcomes across the industry.”